{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T17:23:43Z","timestamp":1775323423495,"version":"3.50.1"},"reference-count":53,"publisher":"The Japan Society of Coloproctology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Anus Rectum Colon"],"published-print":{"date-parts":[[2025,1,25]]},"DOI":"10.23922\/jarc.2024-078","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T22:13:01Z","timestamp":1737756781000},"page":"25-32","source":"Crossref","is-referenced-by-count":2,"title":["Gastroenterological Surgery and Management of &lt;i&gt;Clostridioides difficile&lt;\/i&gt; Infection: A Review"],"prefix":"10.23922","volume":"9","author":[{"given":"Tomonori","family":"Takano","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, St. Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Aiba","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St. Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Kaku","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St. Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kunishima","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, St. Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10009","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Rainey FA, Hollen BJ, Small AM. Clostridium. John Wiley &amp; Sons, Inc.; 2015. Bergey&apos;s manual of systematics of archaea and bacteria; p. 1-122. New jersey, USA.","DOI":"10.1002\/9781118960608.gbm00619"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lawson PA, Citron DM, Tyrrell KL, et al. Reclassification of <i>Clostridium difficile<\/i> as clostridioides difficile (Hall and O&apos;Toole 1935) Pr\u00e9vot 1938. Anaerobe. 2016 Aug;40:95-9.","DOI":"10.1016\/j.anaerobe.2016.06.008"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Leekha S, Aronhalt KC, Sloan LM, et al. Asymptomatic <i>Clostridium difficile<\/i> colonization in a tertiary care hospital: admission prevalence and risk factors. Am J Infect Control. 2013 May;41 (5):390-3.","DOI":"10.1016\/j.ajic.2012.09.023"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of <i>Clostridium difficile<\/i>-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005 Dec;353 (23):2442-9.","DOI":"10.1056\/NEJMoa051639"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kunishima H, Ichiki K, Ohge H, et al. Japanese Society for infection prevention and control guide to <i>Clostridioides difficile<\/i> infection prevention and control. J Infect Chemother. 2024 Aug;30 (8):673-715.","DOI":"10.1016\/j.jiac.2024.03.018"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kunishima H, Ohge H, Suzuki H, et al. Japanese Clinical Practice Guidelines for Management of <i>Clostridioides (Clostridium) difficile<\/i> infection. J Infect Chemother. 2022 Aug;28 (8):1045-83.","DOI":"10.1016\/j.jiac.2021.12.011"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sehgal K, Khanna S. Gut microbiome and <i>Clostridioides difficile<\/i> infection: a closer look at the microscopic interface. Therap Adv Gastroenterol. 2021 Feb;14:1756284821994736.","DOI":"10.1177\/1756284821994736"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gonzales-Luna AJ, Carlson TJ, Garey KW. Gut microbiota changes associated with <i>Clostridioides difficile<\/i> infection and its various treatment strategies. Gut Microbes. 2023 Dec;15 (1):2223345.","DOI":"10.1080\/19490976.2023.2223345"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Deshpande A, Pasupuleti V, Thota P, et al. Risk factors for recurrent <i>Clostridium difficile<\/i> infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2015 Apr;36 (4):452-60.","DOI":"10.1017\/ice.2014.88"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Johnson S. Recurrent <i>Clostridium difficile<\/i> infection: causality and therapeutic approaches. Int J Antimicrob Agents. 2009 Mar;33 (Suppl 1):S33-6.","DOI":"10.1016\/S0924-8579(09)70014-7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Riley TV, Kimura T. The epidemiology of <i>Clostridium difficile<\/i> infection in Japan: a systematic review. Infect Dis Ther. 2018 Mar;7 (1):39-70.","DOI":"10.1007\/s40121-018-0186-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Inghammar M, Svanstr\u00f6m H, Voldstedlund M, et al. Proton-pump inhibitor use and the risk of community-associated <i>Clostridium difficile<\/i> Infection. Clin Infect Dis. 2021 Jun;72 (12):e1084.","DOI":"10.1093\/cid\/ciaa1857"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Park YH, Seong JM, Cho S, et al. Effects of proton pump inhibitor use on risk of <i>Clostridium difficile<\/i> infection: a hospital cohort study. J Gastroenterol. 2019 Dec;54 (12):1052-60.","DOI":"10.1007\/s00535-019-01598-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hess A, Byerly S, Lenart E, et al. Risk factors for <i>clostridium difficile<\/i> infection in general surgery patients. Am J Surg. 2023 Jan;225 (1):118-21.","DOI":"10.1016\/j.amjsurg.2022.09.031"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nguyen KA, Le DQ, Bui YT, et al. Incidence, risk factors, and outcome of <i>Clostridioides difficile<\/i> infection following urological surgeries. World J Urol. 2021 Aug;39 (8):2995-3003.","DOI":"10.1007\/s00345-020-03551-y"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fazl Alizadeh R, Li S, Sullivan B, et al. Surgical outcome in laparoscopic abdominal surgical operations with <i>Clostridium difficile<\/i> infection. Am Surg. 2022 Oct;88 (10):2519-24.","DOI":"10.1177\/00031348221103644"},{"key":"17","unstructured":"17. Terayama K, Honda Y, Baba H, et al. <i>Clostridioides difficile<\/i> infection after cardiovascular surgery: morbidity, background, treatment, and prognosis. J Jpn Soc Surg Infect. 2019;16 (3):180-4."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kunishima H, Ito K, Laurent T, et al. Healthcare burden of recurrent <i>Clostridioides difficile<\/i> infection in Japan: a retrospective database study. J Infect Chemother. 2018 Nov;24 (11):892-901.","DOI":"10.1016\/j.jiac.2018.07.020"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wilcox MH, Ahir H, Coia JE, et al. Impact of recurrent <i>Clostridium difficile<\/i> infection: hospitalization and patient quality of life. J Antimicrob Chemother. 2017 Sep;72 (9):2647-56.","DOI":"10.1093\/jac\/dkx174"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hara T, Suzuki H, Oyanagi T, et al. Clinical evaluation of a non-purified direct molecular assay for the detection of <i>Clostridioides difficile<\/i> toxin genes in stool specimens. PLoS One. 2020 Jun;15 (6):e0234119.","DOI":"10.1371\/journal.pone.0234119"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Planche TD, Davies KA, Coen PG, et al. Differences in outcome according to <i>Clostridium difficile<\/i> testing method: a prospective multicentre diagnostic validation study of <i>C difficile<\/i> infection. Lancet Infect Dis. 2013 Nov;13 (11):936-45.","DOI":"10.1016\/S1473-3099(13)70200-7"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. George WL, Sutter VL, Citron D, et al. Selective and differential medium for isolation of <i>Clostridium difficile<\/i>. J Clin Microbiol. 1979 Feb;9 (2):214-9.","DOI":"10.1128\/jcm.9.2.214-219.1979"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Mileto S, Das A, Lyras D. Enterotoxic clostridia: <i>Clostridioides difficile<\/i> infections. Microbiol Spectr. 2019 May;7 (3):10-1128.","DOI":"10.1128\/microbiolspec.GPP3-0015-2018"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. O&apos;Horo JC, Jones A, Sternke M, et al. Molecular techniques for diagnosis of <i>Clostridium difficile<\/i> infection: systematic review and meta-analysis. Mayo Clin Proc. 2012 Jul;87 (7):643-51.","DOI":"10.1016\/j.mayocp.2012.02.024"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Deshpande A, Pasupuleti V, Rolston DD, et al. Diagnostic accuracy of real-time polymerase chain reaction in detection of <i>Clostridium difficile<\/i> in the stool samples of patients with suspected <i>Clostridium difficile<\/i> Infection: a meta-analysis. Clin Infect Dis. 2011 Oct;53 (7):e81-90.","DOI":"10.1093\/cid\/cir505"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Crobach MJ, Dekkers OM, Wilcox MH, et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing <i>Clostridium difficile<\/i>-infection (CDI). Clin Microbiol Infect. 2009 Dec;15 (12):1053-66.","DOI":"10.1111\/j.1469-0691.2009.03098.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Senoh M, Kato H, Honda H, et al. Performance of laboratory tests for detection for <i>Clostridioides difficile<\/i>: a multicenter prospective study in Japan. Anaerobe. 2019 Dec;60:102107.","DOI":"10.1016\/j.anaerobe.2019.102107"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Xuan S, Zangwill KM, Ni W, et al. Cost-effectiveness analysis of four common diagnostic methods for <i>Clostridioides difficile<\/i> Infection. J Gen Intern Med. 2020 Apr;35 (4):1102-10.","DOI":"10.1007\/s11606-019-05487-5"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Sewell B, Rees E, Thomas I, et al. Cost and impact on patient length of stay of rapid molecular testing for <i>Clostridium difficile<\/i>. Infect Dis Ther. 2014 Dec;3 (2):281-93.","DOI":"10.1007\/s40121-014-0034-x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Peppard WJ, Ledeboer NA. Implementation of polymerase chain reaction to rule out <i>Clostridium difficile<\/i> infection is associated with reduced empiric antibiotic duration of therapy. Hosp Pharm. 2014 Jul;49 (7):639-43.","DOI":"10.1310\/hpj4907-639"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Guinta MM, Bunnell K, Harrington A, et al. Clinical and economic impact of the introduction of a nucleic acid amplification assay for <i>Clostridium difficile<\/i>. Ann Clin Microbiol Antimicrob. 2017 Dec;16 (1):77.","DOI":"10.1186\/s12941-017-0252-7"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Doan TH, Bernet-Camard MF, Ho\u00ffs S, et al. Impact of subinhibitory concentrations of metronidazole on morphology, motility, biofilm formation and colonization of <i>Clostridioides difficile<\/i>. Antibiotics (Basel). 2022 May;11 (5):624.","DOI":"10.3390\/antibiotics11050624"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Darkoh C, Keita K, Odo C, et al. Emergence of clinical <i>Clostridioides difficile<\/i> isolates with decreased susceptibility to vancomycin. Clin Infect Dis. 2022 Jan;74 (1):120-6.","DOI":"10.1093\/cid\/ciaa912"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Yanagihara K, Akamatsu N, Matsuda J, et al. Susceptibility of <i>Clostridium<\/i> species isolated in Japan to fidaxomicin and its major metabolite OP-1118. J Infect Chemother. 2018 Jun;24 (6):492-5.","DOI":"10.1016\/j.jiac.2017.12.006"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Yamagishi Y, Nishiyama N, Koizumi Y, et al. Antimicrobial activity of fidaxomicin against <i>Clostridium difficile<\/i> clinical isolates in Aichi area in Japan. J Infect Chemother. 2017 Oct;23 (10):724-6.","DOI":"10.1016\/j.jiac.2017.04.008"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Kunishima H, Chiba J, Saito M, et al. Antimicrobial susceptibilities of <i>Clostridium difficile<\/i> isolated in Japan. J Infect Chemother. 2013 Apr;19 (2):360-2.","DOI":"10.1007\/s10156-013-0553-5"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Aoki K, Takeda S, Miki T, et al. Antimicrobial susceptibility and molecular characterisation using whole-genome sequencing of <i>Clostridioides difficile<\/i> collected in 82 hospitals in Japan between 2014 and 2016. Antimicrob Agents Chemother. 2019 Sep;63 (12):e01259-19.","DOI":"10.1128\/AAC.01259-19"},{"key":"38","unstructured":"38. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 14.0, 2024 [Internet]. [cited 2024 Jun 22]. Available from: https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_14.0_Breakpoint_Tables.pdf"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Asaoka M, Horita Y, Wachino C, et al. Clinical usefulness of the &quot;MN Criteria&quot; - the <i>Clostridioides difficile<\/i> infection severity scoring system - in the Japanese setting. Intern Med. 2023 Jan;62 (1):59-67.","DOI":"10.2169\/internalmedicine.9540-22"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Tashiro S, Mihara T, Sasaki M, et al. Oral fidaxomicin versus vancomycin for the treatment of <i>Clostridioides difficile<\/i> infection: a systematic review and meta-analysis of randomized controlled trials. J Infect Chemother. 2022 Nov;28 (11):1536-45.","DOI":"10.1016\/j.jiac.2022.08.008"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Okumura H, Ueyama M, Shoji S, et al. Cost-effectiveness analysis of fidaxomicin for the treatment of <i>Clostridioides (Clostridium) difficile<\/i> infection in Japan. J Infect Chemother. 2020 Jun;26 (6):611-8.","DOI":"10.1016\/j.jiac.2020.01.018"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Kim PK, Huh HC, Cohen HW, et al. Intracolonic vancomycin for severe <i>Clostridium difficile<\/i> Colitis. Surg Infect (Larchmt). 2013 Dec;14 (6):532-9.","DOI":"10.1089\/sur.2012.158"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Bratkovi\u010d T, Zahirovi\u0107 A, Bizjak M, et al. New treatment approaches for <i>Clostridioides difficile<\/i> infections: alternatives to antibiotics and fecal microbiota transplantation. Gut Microbes. 2024 Jan-Dec;16 (1):2337312.","DOI":"10.1080\/19490976.2024.2337312"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Jain N, Umar TP, Fahner AF, et al. Advancing therapeutics for recurrent <i>clostridioides difficile<\/i> infections: an overview of vowst&apos;s FDA approval and implications. Gut Microbes. 2023 Jan-Dec;15 (1):2232137.","DOI":"10.1080\/19490976.2023.2232137"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Khanna S, Assi M, Lee C, et al. Efficacy and safety of RBX2660 in PUNCH CD3, a phase III, randomized, double-blind, placebo-controlled trial with a Bayesian primary analysis for the prevention of recurrent <i>Clostridioides difficile<\/i> infection. Drugs. 2022 Oct;82 (15):1527-38.","DOI":"10.1007\/s40265-022-01797-x"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Bobulsky GS, Al-Nassir WN, Riggs MM, et al. <i>Clostridium difficile<\/i> skin contamination in patients with <i>C. difficile<\/i>-associated disease. Clin Infect Dis. 2008 Feb;46 (3):447-50.","DOI":"10.1086\/525267"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Kato H, Hagihara M, Asai N, et al. A systematic review and meta-analysis of decontamination methods to prevent hospital environmental contamination and transmission of <i>Clostridioides difficile<\/i>. Anaerobe. 2022 Feb;73:102478.","DOI":"10.1016\/j.anaerobe.2021.102478"},{"key":"48","unstructured":"48. Kunishima H, Ohge H, Suzuki H, et al, The Japanese Clinical Practice Guidelines for Management of <i>Clostridioides difficile<\/i> infections 2022.Jpn. J. Chemother 2023 71 (1):1-90."},{"key":"49","unstructured":"49. Kunishima H, Ohge H, Suzuki H, et al, The Japanese Clinical Practice Guidelines for Management of <i>Clostridioides difficile<\/i> infections 2022. J.J.A. Inf. D. 2023 97:S1-S96."},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Otter JA, Havill NL, Adams NM, et al. Environmental sampling for <i>Clostridium difficile<\/i>: swabs or sponges? Am J Infect Control. 2009 Aug;37 (6):517-8.","DOI":"10.1016\/j.ajic.2009.01.005"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Engelhardt NEP, Foster NF, Hong S, et al. Comparison of two environmental sampling tools for the detection of <i>Clostridium difficile<\/i> spores on hard bathroom surfaces in the hospital setting. J Hosp Infect. 2017 Jul;96 (3):295-6.","DOI":"10.1016\/j.jhin.2017.03.028"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Claro T, Daniels S, Humphreys H. Detecting <i>Clostridium difficile<\/i> spores from inanimate surfaces of the hospital environment: which method is best? J Clin Microbiol. 2014 Sep;52 (9):3426-8.","DOI":"10.1128\/JCM.01011-14"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Deshpande A, Sitzlar B, Fertelli D, et al. Utility of an adenosine triphosphate bioluminescence assay to evaluate disinfection of <i>Clostridium difficile<\/i> isolation rooms. Infect Control Hosp Epidemiol. 2013 Aug;34 (8):865-7.","DOI":"10.1086\/671272"}],"container-title":["Journal of the Anus, Rectum and Colon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/9\/1\/9_2024-078\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T04:55:26Z","timestamp":1737780926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/9\/1\/9_2024-078\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.23922\/jarc.2024-078","relation":{},"ISSN":["2432-3853"],"issn-type":[{"value":"2432-3853","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,25]]},"article-number":"2024-078"}}